CareDx (NASDAQ: CDNA)
CareDx Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
CareDx Company Info
CareDx, Inc. operates as a transplant diagnostics company, which discovers, develops and commercializes diagnostic solutions. Its products include AlloMap, AlloSure and Laboratory products. The company was founded on December 21, 1998 and is headquartered in Brisbane, CA.
News & Analysis
Investing in Biotech ETFs
Here are the five best biotech ETFs to invest in right now.
Why Shares of CareDx Are Jumping Friday
The company's diagnostic tests may obtain better coverage from the Centers for Medicare & Medicaid Services.
These Charts Explain Why I'm Holding This Healthcare Company
Transplants are in high demand; this company is making the process of getting one smoother.
3 Unstoppable Growth Stocks You Can Buy for Less Than $100 Right Now
It doesn't take a lot to own a piece of these rapidly growing healthcare businesses.
Why Cathie Wood Is Buying Beaten-Down CareDx
Should you follow the internet's favorite stock picker into this tumbling diagnostics stock?
Why CareDx Stock Is Falling Today Despite a Positive Earnings Call
Third-quarter 2021 results were terrific, but the disclosure of two federal investigations isn't sitting well with investors.
This Under-the-Radar Healthcare Company Quietly Surged During the Pandemic
CareDx just posted 76% year-over-year revenue growth for the first quarter and raised its 2021 guidance.
3 Cancer Diagnostic Monster Stocks on Sale
These under-the-radar stocks have had incredible growth over the last 5 years, and are all off over 15% from their highs.
Valuation
Earnings Transcripts
CareDx, Inc (CDNA) Q3 2021 Earnings Call Transcript
CDNA earnings call for the period ending September 30, 2021.
CareDx, inc (CDNA) Q2 2021 Earnings Call Transcript
CDNA earnings call for the period ending June 30, 2021.
CareDx Inc (CDNA) Q1 2021 Earnings Call Transcript
CDNA earnings call for the period ending March 31, 2021.
CareDx Inc (CDNA) Q4 2020 Earnings Call Transcript
CDNA earnings call for the period ending December 31, 2020.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.